Participants with serious adverse reactions · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Physical functioning End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression Measured at end of treatment, 26 weeks · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Depression Long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Sleep · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Physical functioning End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Physical functioning component of health‐related quality of life, measured using various scales · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
2 findings from 1 review
Quality of life ‐ total · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Participant‐reported global assessment‐ total · Patients with osteoarthritis of the knee or hip
Summary of findings table ‐ Adjunctive therapies in addition to… probably leads to higher participant‐reported global assessment‐ total compared with land‐based exercise therapy (moderate certainty).
1 finding from 1 review
Radiographic joint changes · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Adverse events · Patients with osteoarthritis of the knee or hip
Summary of findings table ‐ Adjunctive therapies in addition to… showed no clear difference in adverse events compared with land‐based exercise therapy (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with osteoarthritis of the knee or hip
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain ‐ total · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Physical function · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Pain during activity (short‐term) · patients with patellofemoral pain syndrome (symptoms > 3 weeks (1 study); symptoms > 1 month (3 studies); symptoms > 2 months (2 studies);…
It is very uncertain whether exercise therapy changes pain during activity (short‐term) Scale (0 to 10; higher scores mean… compared with a control strategy (no treatment, placebo or waiting list controls) (very low certainty).
1 finding from 1 review
Usual pain (short‐term) · patients with patellofemoral pain syndrome (symptoms > 3 weeks (1 study); symptoms > 1 month (3 studies); symptoms > 2 months (2 studies);…
It is very uncertain whether exercise therapy changes usual pain (short‐term) Scale (0 to 10; higher scores mean worse pain) compared with a control strategy (no treatment, placebo or waiting list controls) (very low certainty).
1 finding from 1 review